Vagneur J P, Argémi B, Codaccioni J L, Simonin R
Ann Endocrinol (Paris). 1978;39(5):373-85.
The authors studied the clinical characteristics of primary and post-operative hypoparathyroidism in 39 patients. Laboratory follow-up data were compared under two different treatment programs using either AT 10 or 25 Hydroxycholecalciferol (25 OHCC). Clinical analysis revealed the atypical characteristics of primary hypoparathyroidism. From a therapeutic standpoint, AT 10 and 25 OHCC were equally effective in provoking a return to normal plasma calcium levels, except in complex cases of vitamin D resistance. 25 OHCC proved much easier to manipulate than at 10 and offered a higher security with respect tothe risk of hypercalcemia. The biological activity of 25 OHCC seems to differ from that of AT 10, especially regarding phosphorus metabolism.
作者研究了39例原发性及术后甲状旁腺功能减退症患者的临床特征。在使用AT 10或25-羟胆钙化醇(25 OHCC)的两种不同治疗方案下,对实验室随访数据进行了比较。临床分析揭示了原发性甲状旁腺功能减退症的非典型特征。从治疗角度来看,除了维生素D抵抗的复杂病例外,AT 10和25 OHCC在促使血浆钙水平恢复正常方面同样有效。事实证明,25 OHCC比AT 10更易于操作,并且在高钙血症风险方面具有更高的安全性。25 OHCC的生物活性似乎与AT 10不同,尤其是在磷代谢方面。